Regenxbio News, Regenxbio Quote, RGNX Quote

Regenxbio (NQ:RGNX) Delayed: 17.50 -0.52 (2.89%)

Prev. Close

$18.02

Open

$17.83

52 Wk High

$25.00

52 Wk Low

$7.07

Day High

$18.24

Day Low

$17.48

P/E

N/A

EPS

$0.00

Volume

295,968

Apr 4, 2024 04:21 PM Form ARS REGENXBIO Inc. For: Dec 31
Apr 4, 2024 04:16 PM Form DEFA14A REGENXBIO Inc.
Apr 4, 2024 04:11 PM Form DEF 14A REGENXBIO Inc. For: May 31
Mar 28, 2024 07:05 AM Regenxbio (RGNX) Announces Lancet Publication of Phase I/IIa Study of ABBV-RGX-314
Mar 28, 2024 07:05 AM REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD
Mar 27, 2024 04:05 PM REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days
Mar 21, 2024 05:22 PM Form 4 REGENXBIO Inc. For: Mar 19 Filed by: Vasista Vittal
Mar 18, 2024 05:04 PM Form 4 REGENXBIO Inc. For: Mar 14 Filed by: Mills Kenneth T.
Mar 11, 2024 09:32 AM H.C. Wainwright Starts Regenxbio Inc. (RGNX) at Buy; 'Advancing Gene Therapies in Ophthalmology and Rare Diseases'
Mar 11, 2024 08:01 AM Form 8-K REGENXBIO Inc. For: Mar 06

Entities mentioned with RGNX